Variables | Cell-treated group (n = 14) | Control group (n = 14) | p value‡ |
---|---|---|---|
Baseline prior to G-CSF treatment | |||
Red blood cells (RBC) (× 106) | 4.98 ± 0.60 | 4.49 ± 0.56 | 0.036 |
White blood cells (WBC) (× 103) | 8.7 ± 2.2 | 8.9 ± 3.8 | 0.866 |
Hemoglobin (g/dL) | 14.6 ± 1.4 | 13.3 ± 1.7 | 0.033 |
Platelet (× 103/µL) | 237.6 ± 52.3 | 270.9 ± 134.9 | 0.398 |
Segment (%) | 72.8 ± 9.4 | 69.9 ± 8.3 | 0.395 |
Lymphocyte (%) | 18.9 ± 8.4 | 19.6 ± 6.6 | 0.804 |
Compared prior to & after G-CSF treated* | Baseline† | After G-CSF treated† | |
Red blood cells (× 106) | 4.98 ± 0.60 | 4.58 ± 0.57 | < 0.001 |
White blood cells (× 103) | 8.7 ± 2.2 | 49.6 ± 12.1 | 0.005 |
Hemoglobin (g/dL) | 14.6 ± 1.4 | 13.5 ± 1.2 | < 0.001 |
Platelet (× 103/µL) | 237.6 ± 52.3 | 228.4 ± 67.9 | 0.068 |
Segment (SEG) (%) | 72.8 ± 9.4 | 81.8 ± 4.4 | 0.408 |
Lymphocyte (LYM) (%) | 18.9 ± 8.4 | 7.0 ± 2.7 | 0.553 |
HPCs (× 103/µL) | – | 92.8 ± 208.4 | – |